2-(2,3-Difluoro-4-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

Octaethylene Glycol>96.0%(GC)1g

2-((5-Chloropyridin-3-yl)oxy)ethan-1-amine dihydrochloride, 95%, 500mg

1-Ethyl-1H-indazole-3-carboxylic acid, 97%, 25g

1-tert-Butyl 2-methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1,2-dicarboxylate, 95.0%, 25g

2-Methylsulfanylpyrimidine-4-carboxylic acid, 95.0%, 10g

1-Benzyl-4-formylpiperidine, 97.0%, 100g

4-Methyloxazole, 95.0%, 250mg

HPLC column NUCLEODUR® NH2 5 µm, 250 mm, 4.6 mm, 1 Piece(s)

6-Bromo-2-fluoro-3-methylpyridine, 95%, 100mg

(Triphenylphosphoranylidene)acetaldehyde>98.0%(HPLC)5g

Acetic acid, min. 99%, for synthesis, 25 l, plastic packaging.

2-(3-Hydroxyphenoxy)acetic acid, 98%, 500mg